bi-907828
boehringer ingelheim
['bi 907828']
check out the first structure disclosure in the poster session at 1:30 of the mdm2-p53 antagonist bi 907828 - the compound is currently in clinical trials. maybe has set up the poster already early #aacr23
Associate Scientific Director, Computational Biology Oncology at @boehringer 🧬 Data Scientist & KRAS Research. Tweets are my own.